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Summary: 
Anterior ischemic optic neuropathy- Laurent Martini 
 
AION is a condition that involves the impairment or complete loss of vision due to 
damage to the optic nerve from insufficient blood supply. By definition, AION involves 
the first 1mm segment of the optic disc, the optic head. It is very important because it 
constitutes one of the major causes of blindness or seriously impaired vision among 
the middle-aged and elderly population, although no age is spared. AION is divided 
into two main categories according to its etiologies: NAION and AAION. The 
presentation at clinical examination of the two types of AION is similar, but 
differences exist. The biomicroscopic exam shows the color, size of cup (cup-to-disc 
ratio), sharpness of edge, swelling, hemorrhages, notching in the optic disc and any 
other pathological abnormalities. In the case of AION the optic disc is swollen and 
pale. Since this presentation is not specific to this condition, further examination 
methods have to be used like a perimeter to test the visual field of the patient. AAION 
occurs in aproximately 20% of patients with GCA and constitutes 5 to 10% of all 
AION.The pathophysiology of NAION remains unknown but several risk factors and 
conditions have been shown to increase its incidense. NAION is the most frequent 
kind of AION and no treatment has been proven really effective until now, while 
AAION is managed with corticosteroids. 
 
Key words: ophthalmology, optic neuropathy, giant cell arteritis 
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1. Introduction 
 
ON refers to damage to the optic nerve, it is one of the major causes of 
blindness among the middle-aged and elderly population, but it can affect 
people of any age. Damage and loss of neurons lead to the characteristic 
features of ON. Loss of vision is the main symptom, with colors fainting in the 
affected eye. On medical examination with an ophthalmoscope, the head of 
the optic nerve can be visualized, a pale disc is characteristic of long-standing 
optic neuropathy. Most commonly only one eye is affected and it may be 
unnoticed by patients until they are asked to cover the healthy eye during the 
medical examination. 
 
Examination of an eye with an ophthalmoscope 
ON is the end result of any disease that damages nerve cells anywhere 
between the retinal ganglion cells and the lateral geniculate body (anterior 
visual system). 
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It is classified as anterior (optic nerve head) and posterior according to the 
blood supply of the optic nerve. 
The subject of this thesis being AION, we will not talk about the posterior optic 
neuropathies. 
 
1.1. Anatomy of the Optic Tract: 
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The optic nerve is the second pair of cranial nerves. It contains axons that exit 
from the retina, leave the eye at the optic disc and go to the visual cortex 
where inputs from the eye are processed into vision. There are 1.2 million 
optic nerve fibers. 
AION is a disorder that involves impairment or loss of vision due to damage to 
the optic nerve from insufficient blood supply. By definition, AION involves 
the 1mm segment of the optic nerve head, (the optic disc), and results in 
visible disc swelling.  
AION is divided into two types: AAION, and NAION, the later being much 
more frequent. Ischemia of the optic nerve can occur in different anatomical 
locations and can have many etiologies. It is useful to classify these 
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syndromes according to their location and etiology since their presenting 
signs and symptoms as well as treatment and prognosis will depend on that.  
The distinction between AAION and NAION was made to highlight the 
different etiologies of anterior ischemic optic neuropathy. NAION results from 
the coincidence of cardiovascular risk factors in a patient with "crowded" optic 
discs. NAION is more common than AAION and usually occurs in a slightly 
younger group. While only a few cases of NAION result in near total loss of 
vision, most cases of AAION involve nearly complete vision loss. (1) 
In contrast, AAION, is due to giant cell arteritis, an inflammatory disease of 
medium-sized blood vessels that occurs more often in late middle-aged and 
elderly people. (2) 
Overview table comparing AAION and NAAION (3) 
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1.2. The optic disc 
 
The optic disc (optic nerve head) is the place of exit for axons leaving the 
eye. It corresponds to a small physiological blind spot in each eye because 
there are no rods or cones overlying it. 
The optic disc is also the entry point for the major blood vessels that supply 
the retina. 
Anatomy: 
 
The optic disc is placed 3 to 4 mm to the nasal side of the fovea. It is a 
vertical oval, with average dimensions of 1.7mm horizontally by 1.9mm 
vertically. There is a central depression, of variable size, called the optic cup. 
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The terminal portion of the optic nerve and its entrance into the eyeball, in 
horizontal section.(4) 
 
 
 
Schematic diagram of the human	eye, with the optic disc, or blind spot, at the 
bottom.(5) 
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Clinical examination 
 
The eye is unique because of the transparency of its media. Almost all eye 
structures can be examined with appropriate optical equipment and lenses 
because of their transparency. With a direct ophthalmoscope we can visualize 
the optic disc using the principle of reversibility of light. A slit lamp 
biomicroscopic examination and an appropriate aspheric focusing lens are 
required for a detailed stereoscopic view of the optic disc. 
The health of the optic nerve is given by a biomicroscopic exam. The 
ophthalmologist notes the color, size of cup (cup-to-disc ratio), sharpness of 
edge, swelling, hemorrhages, notching in the optic disc and any other 
pathological abnormalities. It is useful for finding evidence corroborating the 
diagnosis of anterior optic neuropathy, glaucoma, optic neuritis, papilledema 
and optic disc drusen. 
A normal healthy optic disc is pink or orange. A pale disc is an indication of a 
pathological condition, including anterior ischemic optic neuropathy. (6) 
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1.3. Imaging of the optic disc 
 
 
 
                           Optic disc showing microvasculature. (7) 
Stereoscopic images are an excellent investigative tool for close follow-up of 
suspected pathological changes in the eye for an ophthalmologist. 
Automated techniques have also been developed to allow more efficient and 
less expensive imaging. They are useful to monitor any changes in optic disc 
morphology and appearance. However imaging will not provide conclusive 
evidence for clinical diagnosis. In order to establish a solid diagnosis other 
medical tests need to be made to prove the presence of functional changes. 
Such tests include visual field charting with a perimeter. Final clinical 
interpretation of the complete eye examination by an eye care physician. (8) 
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Perimeter results: 
 
 
 
 
Normal visual field. (9) 
 
 
 
 
 
Visual field defects in a NAION 
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2. Non arteritic anterior ischemic optic 
neuropathy 
 
NAION is an isolated white-matter stroke of the optic nerve. NAION is the 
most common cause of sudden optic nerve-related vision loss, often 
bilaterally. No clinically effective treatments exist mainly because its 
pathophysiology remains unknown and there are not enough histopathological 
studies of this condition. (10) 
2.1.  Etiology and Risk Factors 
Most cases of NAION are idiopathic but NAION has been found in patients 
suffering from some other conditions although no causal relationship has 
been proved. They are considered to be risk factors; evidence indicates that 
NAION is multifactorial in nature. 
Predisposing risk factors make a person susceptible to develop NAION but 
do not necessarily produce NAION on their own. These may be systemic or 
local in the eye and/or optic nerve head. We can distinguish two categories of 
risk factors. 
a) Systemic risk factors: (11) 
• arterial hypertension, nocturnal arterial hypotension,  
• diabetes mellitus,  
• ischemic heart disease,  
• hyperlipidemia,  
• atherosclerosis and arteriosclerosis, 
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• SAS 
It is unclear how SAS can cause NAION but it is hypothesized that 
apneic spells might result in acute increases in blood pressure, 
intracranial pressure or nocturnal hypoxemia which could cause optic 
nerve edema and ischemia. 
• arterial hypotension due to a variety of causes,  
• malignant arterial hypertension, 
• migraine.  
• medications 
Sildenafil is a treatment for erectile dysfunction by inhibiting PDE5, an 
enzyme that regulates blood flow in the penis. At therapeutic doses this 
medication can cause systemic hypotension. It has been hypothesized 
that it might exaggerate the physiologic nocturnal hypotension resulting 
in ischemia to the optic nerve head and compartment syndrome in 
susceptible patients with small cup to disk ratios. Moreover, it might 
interfere with the autoregulation of blood flow thereby decreasing 
perfusion to the optic nerve head. This association remains very 
controversial.  
b) Ocular and optic nerve head risk factors: 
 A significant association of NAION has been seen with a number of ocular 
and optic nerve head conditions. These include (11) 
• small cup in the optic disc,  
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• angle closure glaucoma or other causes of markedly raised IOP,  
• marked optic disc edema due to any cause,  
• location of the watershed zone of the posterior ciliary arteries in relation 
to the optic disc,  
• optic disc drusen 
Optic disc drusen might increase the risk of developing NAION by 
theoretically contributing to the “crowded” optic nerve in discs with 
small cup to disc ratios. There are anecdotal reports of NAION 
occurring in patients with optic disc drusen but a causal relationship 
has not been proved. 
• cataract extraction.  
• Defective autoregulation of the optic nerve head  
2.2. Pathophysiology 
 
The pathophysiology of NAION is still unknown and no mechanism has been 
definitively accepted. It is supposed to be the consequence of a circulatory 
insufficiency or infarct within the retrolaminar portion of the optic nerve head 
that is supplied by the SPCA. Additional fluorescein and indocyanine studies 
have shown delayed optic disc filling in the prelaminar layers of the optic disc 
with normal choroidal circulation suggesting that the vasculopathy is located 
in the para-optic branches of the SPCA after their branching from the 
choroidal branches rather than in the short ciliary arteries themselves. (12) 
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The cause of the edema of the optic disc is unclear but it is thought that the 
final common pathway leads to a compartment syndrome from axonal edema 
in a structurally crowded optic disc resulting in apoptosis of the retinal 
ganglion cell. (13) 
a) A. Optic Disc Anatomy  
Around 97% of patients with NAION have small optic discs with small optic 
cups. Acutely, it can be difficult to determine the cup/disc ratio because of 
optic nerve edema and the clinician should note the cup/disc ratio in the other 
eye. It is typically less than 0.3mm and these discs are referred to as a “disc 
at risk”. The role of the small cup/disc ratio is unclear but there are probably 
contributory mechanical effects of the small cup/disc ratio in the pathogenesis 
of NAION. A crowded disc can exacerbate chronic mechanical obstruction to 
axoplasmic flow resulting in secondary compression and ischemia. An 
inhibition in axoplasmic flow can inhibit critical neurotrophins leading to 
additional ganglion cell death. (14) 
 
b) Autoregulation  
The optic nerve head efficiently autoregulates blood flow (15). Flow is 
normally maintained constant despite variations in perfusion pressure and 
intraocular pressure under various metabolic conditions and different diseases 
can impair the optic nerve’s ability to autoregulate its blood flow. Systemic 
hypertension, arteriosclerosis, vasospasm or medications may reduce the 
autoregulatory capacity of the optic disc. Vasoactive substances might be 
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released in.  Dr Hayreh has said that the release of endogenous serotonin 
may contribute to optic nerve ischemia by vasoconstricting arterioles and 
impairing autoregulation. (16) 
c) Nocturnal hypotension  
During the night the blood pressure fluctuates and this nocturnal systemic 
hypotension may be a factor to NAION. Patients who have a chronically 
altered optic disc autoregulation, from either systemic hypertension and / or 
atherosclerosis are susceptible to exaggerated decreases in nocturnal blood 
pressure. This effect might be exacerbated when patients are treated with 
strong antihypertensive drugs if they take them before going to bed. (17) 
d) Venous Insufficiency  
NAION might result from venous insufficiency that occurs from closure of 
tributary venules receiving blood from optic nerve capillaries that drain into the 
central retinal vein posterior to the optic nerve head (18). This hypothesis 
comes from the fact that NAION does not have the clinical characteristics of 
an arterial disease. AAION causes a pallid edema that ultimately resolves 
leaving significant excavation and atrophy of the disc whereas NAION 
typically exhibits normal or hyperemic edema that resolves leaving relatively 
preserved disc substance (19). Disc hemorrhages are seen less commonly in 
AAION and central retinal artery occlusion but are more common in NAION 
and central retinal vein occlusion. NAION causes less severe vision loss than 
AAION. Furthermore, the choroidal circulation is typically affected in AAION 
due to SPCA occlusion (and sometimes ophthalmic artery) and occlusion of 
15 
 
this artery in the monkey results in choroidal circulation changes (20). The 
infarct in NAION does not fit the vascular bed of any known artery and 
fluorescein angiography shows normal choroidal filling and slightly delayed 
arterial filling of the prelaminar disc.  
e) Vasculopathic Risk Factors  
NAION is presumed to result from vascular insufficiency but there is no clear 
association of well-known risk factors for ischemic small vessel disease and 
NAION. Lipohyalinosis is suspected in the pathogenesis of NAION but no 
histopathologic confirmation has been demonstrated. Smoking does not seem 
to be an independent risk factor. (21) 
 
2.3.  Symptoms and diagnosis 
 
The typical symptoms of NAION present suddenly and upon awakening. The 
patient sees poorly in one eye. Vision in that eye is diminished by a dark 
shadow, usually involving the upper or lower half of the vision field and the 
area towards the midline, and no pain. Visual acuity improves by at least 3 
lines of vision on the Snellen chart in approximately half of the patients in a 
period of six months. The involvement of the second eye occurs in 15% to 
20% of patients within 5 years. Fortunately it may not be devastating as the 
visual acuity may remain only slightly diminished. Furthermore, in most cases 
NAION involve the loss of a hemifield, upper or lower half of the visual field. 
Only a few patients with NAION suffer from an almost total loss of vision. (22) 
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Since arteritic AION and NAION have an extremely similar presentation, 
patients over the age of 50 diagnosed with NAION must always be evaluated 
to exclude AAION (symptoms: painful jaw muscles, tenderness of scalp, 
weight loss, fatigue, loss of appetite and myalgia, discussed in detail later). 
a) Symptoms 
The typical description of patients with NAION during acute and painless 
unilateral vision loss that is often described is a blurring of vision, often 
inferiorly. The majority of patients do not have accompanying pain, headache 
or periocular pain is encountered in approximately 10% of patients, which 
make it difficult to differentiate from ON. Patients with NAION complain of the 
loss of vision occurring over a few hours, sometimes days. Almost 65% of 
patients report vision loss upon awakening, which suggests that nocturnal 
arterial hypotension may be critically involved in the pathophysiology of 
NAION. (23) 
b) Diagnosis 
Patients presenting with NAION will typically have several symptoms and 
signs of an ON including diminished visual acuity, a swollen optic nerve with 
splinter hemorrhages, dyschromatopsia and a visual field defect. Patients who 
report the classic history of acute, painless, unilateral vision loss and who 
have the typical findings on examination of a swollen and hyperemic optic 
nerve with peripapillary splinter hemorrhages and a small cup to disc ratio, the 
clinical diagnosis is easily made and no further tests are needed. 
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1. Visual Acuity  
Visual acuity varies widely but no light perception is extremely rare and when 
it happens, it should make the ophthalmologist suspects AAION. (23) 
2. Color Vision  
Dyschromatopsia, acquired loss of color vision, is a sign of optic nerve 
malfunction, also very sensitive. The degree of dyschromatopsia in NAION is 
proportional to the visual acuity loss, unlike with optic neuritis. However, 
altitudinal and quadrantic defects are commonly seen in NAION and in these 
cases color vision is often preserved likely due to sparing of the central fibers 
involved in the central vision. (24) 
3. Pupils  
Despite the loss of vision in one eye, the pupils are symmetric and round. 
There is no anisocoria. A relative afferent pupillary defect will be present as 
long as the contralateral eye is normal.  
4. Visual Fields  
Any defect of the visual field in relation to optic nerve damage can occur. 
Almost one patient over four will have central scotomas but the most of them 
will have an altitudinal field loss, most commonly at the inferior portion. (25) 
5. Optic disc and retinal appearance  
The edema of optic disc is always present during the acute phase of NAION 
and it comes in two different varieties, which are diffuse or segmental. 
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Segmental (usually altitudinal) is the most frequent but it does not always 
correspond to the area of visual field loss. The edema is always hyperemic 
and rarely pallid. Pallid edema is more common in AAION so it should alert 
the physician to the probability of GCA, as we will see later in the second part 
of the thesis. Peripapillary splinter hemorrhages are seen in almost 75% of 
patients and it can sometimes be used to help differentiating NAION from 
optic neuritis since they will only be present in 10% of patients with optic 
neuritis. Retinal exudates are uncommon but hard and soft exudates have 
been reported in up to 5% of patients. (26) 
 
2.4.  Causes and risk factors 
 
The pathophysiology of NAION is controversial however most cases involve 
two main risk factors. The first risk factor is a predisposition of certain optic 
discs because of their shape and size. The optic nerve goes through the back 
of the eye and the opening to allow this is 30% larger than the diameter of the 
nerve. In certain patients the optic nerve is almost as big as the hole in the 
back of the eye, and as a result the optic disc appears "crowded" when 
observed by ophthalmoscopy. A crowded disc represents a disc at risk. Even 
though this represents a risk factor, the large majority of individuals will never 
experience NAION.  
The second important risk factor involves general cardiovascular risk factors. 
The major ones are high cholesterol levels, diabetes and hypertension. These 
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conditions predispose a patient to develop NAION, but the most important 
precipitating factor is a dramatic fall of blood pressure during the night 
(nocturnal arterial hypotension), this is the reason why the vast majority of 
patients discover visual loss on waking from sleep. These vascular risk factors 
predispose to ischemia to the optic disc. As a consequence the disc then 
swells and this leads to compression and increases ischemia.  (27) 
Since the shape of both eyes tend to be similar, the clinician needs to look at 
the healthy eye to assess the anatomical predisposition. The unaffected eye 
has a 16% risk of NAION within five years.  
 
2.5. Treatment 
 
Once NAION happens, if patients are treated with corticosteroids in large 
doses during the early stage there is visual acuity improvement in almost 
three quarters of them. According to  Dr. Sohan Singh Hayreh, from Iowa in 
his article “Anterior Optic Neuropathy, part II a discution for physicians” 
“The sooner the treatment is started, the better are the chances of visual 
improvement. That may be because the shorter the duration of axonal 
ischemia, the fewer axons are likely to be damaged permanently(...)I have 
found that the most effective way to use corticosteroid therapy is to hit hard at 
the beginning and then taper down. The major flaw in the way corticosteroid 
therapy has been given for NAION in some studies is "too small a dose, for 
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too short a period". This timidity has led to the prevailing misconception that 
corticosteroid therapy does not help NAION”. (27) 
	In order to decrease the risk of further visual loss in the other eye or the same 
eye, it is essential to minimize and control the risk factors. First of all trying to 
control the cardiovascular risk factors to avoid seeing the same condition 
happening to the second eye. Sudden vision loss should always lead to an 
urgent ophthalmological consultation. A neuro-ophthalmologist's consultation 
should be obtained if NAION is suspected. (28) 
Thrombosis therapy does not reduce the severity of NAION or shorten the 
visual disturbance.
	
	
3. Arteritic anterior ischemic optic 
neuropathy 
 
AAION occurs in about 20% of patients with GCA also called temporal 
arteritis or Horton’s disease. GCA is a systemic vasculitis that affects the 
temporal arteries primarily. In the eye, it involves the posterior ciliary artery 
leading to occlusion due to thrombosis (29). The result is development of 
AAION and severe visual loss. 
When the blood vessels supplying the optic nerves get damaged, it leads to 
ischemia of the nerve and optic nerve fiber death if not treated promptly. Most 
cases of AAION result in nearly complete vision loss to one eye first. If the 
temporal arteritis is left untreated, the second eye is probably going to suffer 
vision loss as well in less that two weeks. Ischemia that occurs at the head of 
the optic nerve impairs perfusion and producing optic disc edema, giving a 
similar appearance that in NAION on ophthalmoscope. AAION is considered 
an eye emergency, immediate treatment is essential to rescue remaining 
vision. This condition is painless and acute, it occurs predominantly in patients 
over 70 years old; it is three times more common in women than in men. The 
racial differences suggest a genetic predisposition to giant cell arteritis being 
more often seen in Caucasian population. (30) 
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Optic nerve vascularization (31)
	
	
 
 
Schematic representation of blood supply of: (A) the optic 
nerve head and (B) the optic nerve (32) 
 
 
Abbreviations: A = arachnoid; C = choroid; CRA = central retinal artery; Col. 
Br.  = Collateral branches; CRV = central retinal vein; D = dura; LC = lamina 
cribrosa; NFL = surface nerve fiber layer of the disc; OD = optic disc; ON = 
optic nerve; P = pia; PCA = posterior ciliary artery; PR and PLR = prelaminar 
region; R = retina; RA = retinal arteriole; S = sclera; SAS = subarachnoid 
space. 
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3.1. Pathogenesis  
It accounts for only 5-10% of AION and inflammation and thrombosis of the 
SPCA or other arteries supplying the optic nerve head resulting in infarction, 
optic disc swelling, chronic inflammatory cells infiltration and necrosis of the 
nerve if left untreated. Extremely poor or absent filling of the choroid has been 
depicted as a characteristic of AAION.  
The pathological mechanism seems to starts when dendritic cells in the 
vessel wall recruiting T cells and macrophages to form granulomatous 
infiltrates. There is infiltration of lymphocytes, monocytes and neutophils in the 
arterial walls, destruction of the muscle cells in the media and fragmentation 
of the elastic fibers. Cytokines are increased and play a central role in the 
inflammatory pathogenesis. (33) 
 
 
Microscopic pathology image showing a normal temporal artery biopsy on an 
elastic stain performed for a Giant cell temporal arteritis. (34)
	
	
3.2. Symptoms  
a) General Symptoms: 
The symptoms of GCA usually are systemic and not specific, including weight 
loss, anorexia, scalp tenderness, headache, abnormal temporal artery, 
myalgia, neck pain, malaise and anemia, and the most characteristic 
symptom jaw claudication (spasms of the jaw muscle), joint and muscle pain, 
and ear pain. (35) 
b) Ocular Manifestations  
AAION may occur as an ocular manifestation of the vasculitis related to GCA 
in 5-10% of the cases. Rapid onset of painless, unilateral visual loss 
manifested by decreased visual acuity that is severe in over 70% of the 
patients, visual field or both. Compared to NAION, the visual defects are 
much more extensive and severe in AAION (36). A relative afferent pupillary 
defect is common in unilateral neuropathies. Pallor of the optic disc, which 
may be severe, chalky-white is the hallmark of AAION, but it’s not uncommon 
to see hyperemic swelling. The disc most often is swollen diffusely, but a 
segment of more prominent involvement may be present with flame 
hemorrhages located adjacent to the disc, and the peripapillary retinal 
arterioles frequently are narrowed. Choroidal ischemia may be associated 
with the optic neuropathy and produces peripapillary pallor and edema deep 
to the retina. The disc of the fellow eye is of normal diameter in AAION, as is 
the physiologic cup, which is different than in NAION where the cup is smaller. 
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Occult GCA without overt systemic symptoms happens and it occurs in 
approximately 20% of patients with AAlON. (37) 
Besides the several systemic symptoms of GSA that help in diagnosis of 
AAION such as jaw claudication, scalp tenderness, unintentional weight loss, 
fatigue, myalgia and loss of appetite there are also elevations in three blood 
tests that help identify AAION: ESR, CRP and platelet count. A related 
rheumatic disease called polymyalgia rheumatica has a 15% incidence of 
GCA. Nevertheless, many cases are asymptomatic. 
Early diagnosis is of first importance since the sudden blindness in the 
affected eye is often followed, within days, by similar symptoms in the second 
eye. Prompt treatment prevents further damage. Any patient diagnosed with 
NAION over the age of 50 must be questioned about the general symptoms 
mentioned earlier. Moreover, AION patients older than 75 should always be 
blood tested. 
3.3. Diagnosis  
Measurement of the ESR remains the standard, which usually elevates up too 
70-120mm/min in GCA. Serum CRP concentration measurement may help in 
diagnosis. It has been reported a 97% specificity for temporal arteritis in cases 
of AION in which both ESR and CRP were elevated. Confirmation of the 
diagnosis of temporal arteritis by superficial temporal artery biopsy is 
recommended in cases of AION with clinical suspicion of arteritis. Positive 
biopsy findings are: intimal thickening, internal limiting lamina fragmentation, 
and chronic inflammatory infiltrate with giant cells. They are confirmatory for 
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GCA (38). A negative biopsy doesn’t rule out AAION (5% false-negative error 
rate). OCT is useful in assessing the disc edema, retinal nerve fiber layer 
thickness, as well as documenting the resolution to a normal or an atrophic 
optic disc. (39) 
3.4. Differential Diagnosis  
The differential diagnosis of AION include: idiopathic optic neuritis, optic nerve 
inflammation related to syphilis or sarcoidosis (because of the granulomatous 
inflammation), infiltrative optic neuropathies, anterior orbital lesions with optic 
nerve compression, and diabetic papillopathy. (40) 
3.5. Treatment 
Corticosteroids are the treament of choice. Typically high-dose prednisone 
(1 mg/kg/day) must be started as soon as possible when the diagnosis of 
arteritis temporalis is suspected, even before the diagnosis is confirmed by 
biopsy in order to prevent irreversible blindness secondary to ophthalmic	artery 
occlusion. IV methylprednisolone at 1g/day for the first 3 days has been 
recommended for severe cases. (41) 
Steroids do not compromise the diagnosis by biopsy even though some 
histological changes might be observed after the first week of treatment and 
are more difficult to identify later. (42) 
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3.6. Course and Outcome  
 
Without therapy visual loss happens in more than half of the patients typically 
in 4 to 6 months according to the literature. With corticosteroid treatment the 
rate of visual loss is reduced to an estimated 15%. Visual recovery of the 
affected eye that is treated is poor with only a 25% improvement rate, higher 
with intravenous therapy though. Worsening of visual acuity has been 
reported in 15% despite the therapy. (43) 
 
 
	
	
4. Differentiation of AAION from NAION 
  
When a patient is diagnosed with AION, the first and critical step in patients 
older than 50 is to identify as soon as possible whether it is AAION or NAION. 
Clinical examination and investigation give information helping to differentiate 
the two types of AION with a certain success. 
1. Systemic symptoms of giant cell arteritis: however, 20% with occult 
GCA do not have systemic symptoms and visual loss is the only 
complaint. Patients with never NAION systemic symptoms of giant cell 
arteritis. So if the systemic symptoms are present we can rule out 
NAION but if they are absent we can not elliminate AAION of the 
differential diagnosis. 
2. Visual symptoms: amaurosis fugax is highly suggestive of AAION and 
is extremely rare in NAION.  
3. Blood test: hematologic abnormalities. Immediate evaluation of ESR 
and CRP is vital in all patients older than 50. Elevated ESR and CRP, 
particularly CRP, is crucial in the diagnosis of GCA. Patients with 
NAION do not show those abnormalities, unless in the presence of 
another disease.  
4. Sudden, acute and important visual loss: suggestive of AAION. 
However, the presence of a normal visual acuity does not rule out 
AAION.  
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5. Chalky white optic disc edema: seen in 70% of AAION eyes and is 
almost diagnostic. In NAION, chalky white optic disc edema occurs 
only very rarely with embolic occlusion of the SPCA.  
6. AAION associated with SPCA occlusion: this is in most cases 
diagnostic of AAION.    
7. Temporal artery biopsy: this test finally establishes the diagnosis with 
certainty. 
AION is not one disease but a spectrum of several different types, each with a 
different etiology, risk factors, pathogenesis, management and treatment. 
They must be considered a separate clinical entity. Put together they 
constitute one of the major causes of blindness or severely impaired vision, 
yet their pathogeneses and management are not well understood and 
controled.(44)
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